Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV Vaccine Co-administered With Td Vaccine in Healthy Adolescents
NCT07824310Phase 3Not yet recruiting
- Sponsor
- Bio Farma
- Start
- Oct 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle in human papillomavirus infection, sponsored by Bio Farma. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like particle
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT07824310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07824310.